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   A survey was made to determine how much mass screening for prostatic cancer (PC) and be-
nign prostatic hypertrophy (BPH) would benefit the nation economically. Presently in Japan, ap-
proximately 20,000 people are suffering from PC, approximately 0.2% of the male population over 
the age of 55. Approximately 37 billion yen is spended annually to treat them with current medi-
cal care. This amounts to approximately 0.3% of the annual national medical fee for all diseases 
and approximately 4% for malignant neoplasms. However, if all adult males participated in a mass 
screening program for prostatic cancer once every two years, a program already established by us, 
eradication of PC may be theoretically possible at the cost of approximately 31 billion yen per year. 
Mass screening for prostatic cancer will thus contribute highly to both the reduction of the national 
medical costs and the decrease of deaths from cancer. The nation also spends heavily on BPH. 
There is an urgent need to recognize that BPH is a heavy burden on the national economy, and 
to consider a proper counterplan. 






























































































































とい う関係が成 り立つ.有 病期間をxと して先に求め
た前立腺癌有病者数および1985年の前立腺癌罹患者数
を代入すると
子 に お け る前 立 腺 癌 の 割合 は
18,326=0.17%10
,787,900






病期間は,ほ ぼ4年 と考えられる.ま たstageBの



















































































































































































る.こ の よ うな 動 きを 少 しで も拡 げ てゆ くこ とが,そ
の ま まantionaldamagcを経 済 的 に も倫 理 的 に も減
少 させ る結 果 に つ な が る ことが,今 回 のanalysisに
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